Inventor
John J. Clifford
Inventor
Bedford, MA, US
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds33%
C07CAcyclic or carbocyclic compounds24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium14%
A61KPreparations for medical, dental or toiletry purposes10%
PatentTitleYear
7,531,573'Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease'20097,342,038'Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation'20086,992,079'Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation'20066,800,658'Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment of prevention of diseases characterized by abnormal cell proliferation'20046,534,497'Substitute 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation'20036,331,564'Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease'20016,127,407'Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment of prevention of diseases characterized by abnormal cell proliferation'20006,043,272'Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment of prevention of diseases characterized by abnormal cell proliferation'20006,028,103'Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation'2000Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2000–2009Patents assigned to CHILDRENS MEDICAL CENTER (5)· patent assignee history
2000–2008Patents assigned to NUCHEM PHARMACEUTICALS INC (5)· patent assignee history
2000–2008Patents assigned to HARVARD COLLEGE (4)· patent assignee history
2000–2009Based in Bedford, MA, US· patent location history
2000–2006Based in Arlington, MA, US· patent location history
2001Patents assigned to ION PHARMACEUTICALS INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CHILDRENS MEDICAL CENTER | 5 | 2000–2009 |
| NUCHEM PHARMACEUTICALS INC | 5 | 2000–2008 |
| HARVARD COLLEGE | 4 | 2000–2008 |
| ION PHARMACEUTICALS INC | 1 | 2001 |
Locations
| Location | Patents | Span |
|---|---|---|
| Bedford, Massachusetts, US | 5 | 2000–2009 |
| Arlington, Massachusetts, US | 4 | 2000–2006 |